Correction: Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come,Molecular Neurodegeneration

当前位置： X-MOL 学术 › Mol. Neurodegener. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Correction: Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come
Molecular Neurodegeneration ( IF 15.1 ) Pub Date : 2023-11-09 , DOI: 10.1186/s13024-023-00678-5
John J Alam ₁ , Ralph A Nixon _{2,

3}

Affiliation

Molecular Neurodegeneration (2023) 18:74

https://doi.org/10.1186/s13024-023-00663-y

In the original article [1] the following statement of funding acknowledgement was mistakenly omitted:

“Preclinical studies have been supported by NIH grants P01AG017617 and R01AG062376 grants to RAN.”

Authors and Affiliations

CervoMed Inc, 20 Park Plaza, Suite 424, Boston, MA, 02116, USA
John J. Alam
Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA
Ralph A. Nixon
Departments of Cell Biology and Psychiatry, NYU Langone Medical Center, NYU Neuroscience Institute, New York, NY, USA
Ralph A. Nixon

Authors

John J. AlamView author publications
You can also search for this author in PubMed Google Scholar
Ralph A. NixonView author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John J. Alam.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s13024-023-00663-y.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

Cite this article

Alam, J.J., Nixon, R.A. Correction: Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come. Mol Neurodegeneration 18, 81 (2023). https://doi.org/10.1186/s13024-023-00678-5

Download citation

Published: 09 November 2023
DOI: https://doi.org/10.1186/s13024-023-00678-5

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

中文翻译：

更正：针对基底前脑胆碱能系统退化的药物开发：时机已经到来

分子神经变性（2023）18:74

https://doi.org/10.1186/s13024-023-00663-y

在原始文章[1]中，错误地省略了以下资助致谢声明：

“临床前研究得到了 NIH P01AG017617 拨款和 RAN R01AG062376 拨款的支持。”

作者和单位

CervoMed Inc, 20 Park Plaza, Suite 424, Boston, MA, 02116, 美国
约翰·J·阿拉姆
内森·克莱恩精神病学研究所痴呆症研究中心，美国纽约州奥兰治堡
拉尔夫·尼克松
细胞生物学和精神病学系，纽约大学朗格尼医学中心，纽约大学神经科学研究所，纽约，纽约州，美国
拉尔夫·尼克松

作者

约翰·J·阿拉姆查看作者出版物
您也可以在PubMed Google Scholar中搜索该作者
拉尔夫·尼克松查看作者出版物
您也可以在PubMed Google Scholar中搜索该作者

通讯作者

通讯作者：约翰·J·阿拉姆。

出版商备注

施普林格·自然对于已出版的地图和机构隶属关系中的管辖权主张保持中立。

原始文章的在线版本可以在 https://doi.org/10.1186/s13024-023-00663-y 找到。

开放获取本文根据知识共享署名 4.0 国际许可证获得许可，该许可证允许以任何媒介或格式使用、共享、改编、分发和复制，只要您对原作者和来源给予适当的认可，提供知识共享许可的链接，并指出是否进行了更改。本文中的图像或其他第三方材料包含在文章的知识共享许可中，除非材料的出处中另有说明。如果文章的知识共享许可中未包含材料，并且您的预期用途不受法律法规允许或超出了允许的用途，则您需要直接获得版权所有者的许可。要查看此许可证的副本，请访问 http://creativecommons.org/licenses/by/4.0/。知识共享公共领域奉献豁免 (http://creativecommons.org/publicdomain/zero/1.0/) 适用于本文中提供的数据，除非数据的信用额度中另有说明。

转载和许可